Literature DB >> 12625822

Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.

Rabuesak Khumthong1, Pornwarat Niyomrattanakit, Santad Chanprapaph, Chanan Angsuthanasombat, Sakol Panyim, Gerd Katzenmeier.   

Abstract

The N-terminal part of the NS3 protein from dengue virus contains a trypsin-like serine protease responsible for processing the nonstructural region of the viral polyprotein. Enzymatic activity of the NS2B-NS3(pro) precursor incorporating a full-length NS2B cofactor of dengue virus type 2 was examined by using synthetic dodecamer peptide substrates encompassing native cleavage sequences of the NS2A/NS2B, NS2B/NS3, NS3/NS4A and NS4B/NS5 polyprotein junctions. Cleavage of the dansylated substrates was monitored by a HPLC-based assay and kinetic parameters for K(1M), k(cat) and k(cat)/K(m) were obtained. The data presented here show that NS2B-NS3(pro) expressed in recombinant E. coli can be renatured to an active protease which reacts in the absence of microsomal membranes with all 4 substrate peptides, albeit the molecule does not exhibit autoproteolytic processing at the NS2B/NS3 site. A marked difference in cleavage efficiency was found for the NS2B/NS3 substrate and the remaining 3 peptides based on the NS2A/NS2B, NS3/NS4A and NS4A/NS5 cleavage sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12625822     DOI: 10.2174/0929866033408228

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  8 in total

1.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

Review 2.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

3.  Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

Authors:  Sergey A Shiryaev; Igor A Kozlov; Boris I Ratnikov; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

4.  Enzymatic characterization of a trypsin-like serine protease encoded by the genome of cell fusing agent virus.

Authors:  Christophe N Peyrefitte; Boris A M Pastorino; Marc Grandadam; Dominique Rolland; Hugues J Tolou; Maël Bessaud
Journal:  Virus Genes       Date:  2006-12-02       Impact factor: 2.332

5.  Prodrug Activation by a Viral Protease: Evaluating Combretastatin Peptide Hybrids To Selectively Target Infected Cells.

Authors:  Michael Richter; Mila M Leuthold; Dominik Graf; Ralf Bartenschlager; Christian D Klein
Journal:  ACS Med Chem Lett       Date:  2019-07-18       Impact factor: 4.345

6.  Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.

Authors:  Pornwaratt Niyomrattanakit; Pakorn Winoyanuwattikun; Santad Chanprapaph; Chanan Angsuthanasombat; Sakol Panyim; Gerd Katzenmeier
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.

Authors:  Pornwaratt Niyomrattanakit; Sviatlana Yahorava; Ilze Mutule; Felikss Mutulis; Ramona Petrovska; Peteris Prusis; Gerd Katzenmeier; Jarl E S Wikberg
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

8.  Development of a NS2B/NS3 protease inhibition assay using AlphaScreen® beads for screening of anti-dengue activities.

Authors:  Muhammad Asyraf Abduraman; Maywan Hariono; Rohana Yusof; Noorsaadah Abd Rahman; Habibah A Wahab; Mei Lan Tan
Journal:  Heliyon       Date:  2018-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.